HIMS

Hims & Hers Health, Inc.

There isn't enough reported data to score HIMS yet.

NOK

Nokia Oyj

65
Fundamentals66/ 100
Valuation50/ 100
Upside potential60/ 100
Risk potential31/ 100

NOK lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.

HIMS Fundamentals

MetricStatus
Strong
Weak
Stable
Strong

HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.

NOK Fundamentals

MetricStatus
Stable
Healthy
Under pressure
Strong

NOK's profitability and balance sheet are currently healthy, and its revenue is stable, but its cash flow is under pressure.

HIMS PE Valuation

HIMS has no meaningful PE right now: it lost money over the past year.

NOK PE Valuation

NOK has no meaningful PE right now: it lost money over the past year.

HIMS Forward outlook

MetricOutlook
--
Turning to a loss
Strong growth
Stable
Limited
Low

Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.

NOK Forward outlook

MetricOutlook
--
Strong growth
Growth
Strongly improving
Limited
Low

NOK has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.

HIMS Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $19.73 on Nov 12.

There is not enough scenario data to compare HIMS and NOK's risk to reward.

NOK Risk to reward

ScenarioChangePrice
Upside+47%$12.15
Downside-31%$5.71

Calculated from the latest close: $8.28 on Nov 12.

There is not enough scenario data to compare HIMS and NOK's risk to reward.

HIMS Earnings Per Share

Q4 2023: $-0.11Q1 2024: $-0.01Q2 2024: $0.08Q3 2024: $0.44Q4 2024: $0.53Q1 2025: $0.68Q2 2025: $0.79Q3 2025: $0.53Q4 2025: $0.51Q1 2026: $-0.09Q2 2026: $-0.63Q3 2026: $-0.83
Q4 2023: $-0.11Q1 2024: $-0.01Q2 2024: $0.08Q3 2024: $0.44Q4 2024: $0.53Q1 2025: $0.68Q2 2025: $0.79Q3 2025: $0.53Q4 2025: $0.51Q1 2026: $-0.09Q2 2026: $-0.63Q3 2026: $-0.83
QuarterTTM EPSYoY
Q3 2026-$0.83-257%
Q2 2026-$0.63-180%
Q1 2026-$0.09-113%
Q4 2025$0.51-3.8%
Q3 2025$0.53+20%
Q2 2025$0.79+888%
Q1 2025$0.68+$0.69
Q4 2024$0.53+$0.64

HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.

NOK Earnings Per Share

Q4 2023: $0.13Q1 2024: $0.16Q2 2024: $0.07Q3 2024: $0.08Q4 2024: $0.15Q1 2025: $0.05Q2 2025: $0.11Q3 2025: $0.09Q4 2025: $0.13Q1 2026: $0.16Q2 2026: $0.14Q3 2026: $0.15
Q4 2023: $0.13Q1 2024: $0.16Q2 2024: $0.07Q3 2024: $0.08Q4 2024: $0.15Q1 2025: $0.05Q2 2025: $0.11Q3 2025: $0.09Q4 2025: $0.13Q1 2026: $0.16Q2 2026: $0.14Q3 2026: $0.15
QuarterTTM EPSYoY
Q3 2026$0.15+67%
Q2 2026$0.14+27%
Q1 2026$0.16+220%
Q4 2025$0.13-13%
Q3 2025$0.09+13%
Q2 2025$0.11+57%
Q1 2025$0.05-69%
Q4 2024$0.15+15%

NOK has the edge over HIMS on earnings quality, reporting a profit while its opponent remains loss making.

HIMS Quarterly Revenue

Q4 2023: $247MQ1 2024: $278MQ2 2024: $316MQ3 2024: $402MQ4 2024: $481MQ1 2025: $586MQ2 2025: $545MQ3 2025: $599MQ4 2025: $618MQ1 2026: $608MQ2 2026: $753MQ3 2026: $890M
Q4 2023: $247MQ1 2024: $278MQ2 2024: $316MQ3 2024: $402MQ4 2024: $481MQ1 2025: $586MQ2 2025: $545MQ3 2025: $599MQ4 2025: $618MQ1 2026: $608MQ2 2026: $753MQ3 2026: $890M
QuarterRevenueYoY
Q3 2026$890.4M+49%
Q2 2026$753.2M+38%
Q1 2026$608.1M+3.8%
Q4 2025$617.8M+28%
Q3 2025$599M+49%
Q2 2025$544.8M+73%
Q1 2025$586M+111%
Q4 2024$481.1M+95%

HIMS has the edge over NOK on sales, with more consistent year-over-year improvement.

NOK Quarterly Revenue

Q4 2023: $6.3BQ1 2024: $4.9BQ2 2024: $5BQ3 2024: $4.8BQ4 2024: $6.6BQ1 2025: $4.9BQ2 2025: $5.1BQ3 2025: $5.4BQ4 2025: $6.8BQ1 2026: $5BQ2 2026: $5.3BQ3 2026: $5.7B
Q4 2023: $6.3BQ1 2024: $4.9BQ2 2024: $5BQ3 2024: $4.8BQ4 2024: $6.6BQ1 2025: $4.9BQ2 2025: $5.1BQ3 2025: $5.4BQ4 2025: $6.8BQ1 2026: $5BQ2 2026: $5.3BQ3 2026: $5.7B
QuarterRevenueYoY
Q3 2026$5.7B+6.1%
Q2 2026$5.3B+5.9%
Q1 2026$5B+2.4%
Q4 2025$6.8B+2.4%
Q3 2025$5.4B+12%
Q2 2025$5.1B+1.8%
Q1 2025$4.9B-1.2%
Q4 2024$6.6B+4.9%

NOK's revenue is recovering but still below its 2022 peak: $5.7B last quarter, up 6.1% from the same quarter a year ago.

HIMS Free Cash Flow

Q4 2023: $22MQ1 2024: $26MQ2 2024: $54MQ3 2024: $85MQ4 2024: --Q1 2025: $50MQ2 2025: −$70MQ3 2025: $79MQ4 2025: −$3MQ1 2026: $53MQ2 2026: −$68MQ3 2026: $26M
Q4 2023: $22MQ1 2024: $26MQ2 2024: $54MQ3 2024: $85MQ4 2024: --Q1 2025: $50MQ2 2025: −$70MQ3 2025: $79MQ4 2025: −$3MQ1 2026: $53MQ2 2026: −$68MQ3 2026: $26M
QuarterFree cash flowYoY
Q3 2026$26M-67%
Q2 2026-$68.2M+$1.3M
Q1 2026$53.1M+5.9%
Q3 2025$79.3M-7%
Q2 2025-$69.5M-230%
Q1 2025$50.1M+94%
Q3 2024$85.3M+238%
Q2 2024$53.6M+219%

HIMS has the edge over NOK on cash flow, with more consistent year-over-year improvement.

NOK Free Cash Flow

Q4 2023: $1.9BQ1 2024: $1.1BQ2 2024: $438MQ3 2024: $754MQ4 2024: $56MQ1 2025: $801MQ2 2025: $98MQ3 2025: $477MQ4 2025: $252MQ1 2026: $699MQ2 2026: −$832MQ3 2026: −$112M
Q4 2023: $1.9BQ1 2024: $1.1BQ2 2024: $438MQ3 2024: $754MQ4 2024: $56MQ1 2025: $801MQ2 2025: $98MQ3 2025: $477MQ4 2025: $252MQ1 2026: $699MQ2 2026: −$832MQ3 2026: −$112M
QuarterFree cash flowYoY
Q3 2026-$112M-123%
Q2 2026-$832.1M-951%
Q1 2026$698.8M-13%
Q4 2025$252.2M+354%
Q3 2025$476.6M-37%
Q2 2025$97.8M-78%
Q1 2025$801M-25%
Q4 2024$55.5M-97%

NOK usually generates cash, though not every quarter: the latest was −$112M, but it generated $7M over the past year.

HIMS Total Shares

Q4 2023: 209MQ1 2024: 229MQ2 2024: 235MQ3 2024: 235MQ4 2024: 237MQ1 2025: 247MQ2 2025: 257MQ3 2025: 249MQ4 2025: 258MQ1 2026: 228MQ2 2026: 232MQ3 2026: 234M
Q4 2023: 209MQ1 2024: 229MQ2 2024: 235MQ3 2024: 235MQ4 2024: 237MQ1 2025: 247MQ2 2025: 257MQ3 2025: 249MQ4 2025: 258MQ1 2026: 228MQ2 2026: 232MQ3 2026: 234M
PeriodChange %Net change
Quarterly+0.9%+2.1M shares
1 year-6%-14.9M shares
3 years+11%+23.7M shares
5 years+17%+33.8M shares

HIMS has the edge over NOK on shareholder dilution, with a more favorable share count trend.

NOK Total Shares

Q4 2023: 5.5BQ1 2024: 5.6BQ2 2024: 5.5BQ3 2024: 5.5BQ4 2024: 5.5BQ1 2025: 5.4BQ2 2025: 5.5BQ3 2025: 5.5BQ4 2025: 5.5BQ1 2026: 5.7BQ2 2026: 5.8BQ3 2026: 5.7B
Q4 2023: 5.5BQ1 2024: 5.6BQ2 2024: 5.5BQ3 2024: 5.5BQ4 2024: 5.5BQ1 2025: 5.4BQ2 2025: 5.5BQ3 2025: 5.5BQ4 2025: 5.5BQ1 2026: 5.7BQ2 2026: 5.8BQ3 2026: 5.7B
PeriodChange %Net change
Quarterly-1%-56.5M shares
1 year+4.7%+257M shares
3 years+2.6%+148M shares
5 years+0.9%+54M shares
Available history+2.2%+123M shares

NOK has 5.7B diluted shares, up 4.7% from a year ago.

HIMS Net Leverage

Q1 2024: -49.8xQ2 2024: -5.5xQ3 2024: -2.9xQ4 2024: -2.8xQ1 2025: -2.1xQ2 2025: -7.3xQ3 2025: -2.2xQ4 2025: -1.4xQ1 2026: -5.9x
Q1 2024: -49.8xQ2 2024: -5.5xQ3 2024: -2.9xQ4 2024: -2.8xQ1 2025: -2.1xQ2 2025: -7.3xQ3 2025: -2.2xQ4 2025: -1.4xQ1 2026: -5.9x
QuarterNet LeverageStatus
Q1 2026-5.9xNet Cash
Q4 2025-1.4xNet Cash
Q3 2025-2.2xNet Cash
Q2 2025-7.3xNet Cash
Q1 2025-2.1xNet Cash
Q4 2024-2.8xNet Cash
Q3 2024-2.9xNet Cash
Q2 2024-5.5xNet Cash

HIMS has more cash than debt.

NOK Net Leverage

Q4 2023: -0.4xQ1 2024: -0.6xQ2 2024: -0.8xQ3 2024: -0.8xQ4 2024: -0.5xQ1 2025: -0.2xQ2 2025: -0.3xQ3 2025: -0.3xQ4 2025: -0.1xQ1 2026: -0.7xQ2 2026: -0.5xQ3 2026: -0.3x
Q4 2023: -0.4xQ1 2024: -0.6xQ2 2024: -0.8xQ3 2024: -0.8xQ4 2024: -0.5xQ1 2025: -0.2xQ2 2025: -0.3xQ3 2025: -0.3xQ4 2025: -0.1xQ1 2026: -0.7xQ2 2026: -0.5xQ3 2026: -0.3x
QuarterNet LeverageStatus
Q3 2026-0.3xNet Cash
Q2 2026-0.5xNet Cash
Q1 2026-0.7xNet Cash
Q4 2025-0.1xNet Cash
Q3 2025-0.3xNet Cash
Q2 2025-0.3xNet Cash
Q1 2025-0.2xNet Cash
Q4 2024-0.5xNet Cash

NOK has more cash than debt.

HIMS Weekly Momentum

MetricValueStatus
RSI36.0Neutral
Stochastic23.0Neutral

HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).

NOK Weekly Momentum

MetricValueStatus
RSI40.8Neutral
Stochastic18.3Oversold

NOK's weekly RSI is 41 (neutral) and its Stochastic is 18 (oversold).

HIMS PE vs Healthcare Sector

MetricHIMSSector medianRelative
PEN/A26x—

HIMS has no meaningful PE right now: it lost money over the past year.

NOK PE vs Technology Sector

MetricNOKSector medianRelative
PEN/A28x—

NOK has no meaningful PE right now: it lost money over the past year.

HIMS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$27.328% below
20 week MA$29.232% below
50 week MA$27.729% below
100 week MA$35.945% below
200 week MA$24.419% below

HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.

NOK Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$9.149.4% below
20 week MA$9.9217% below
50 week MA$9.6614% below
100 week MA$7.3513% above
200 week MA$5.6746% above

NOK has the edge over HIMS on trend strength, trading above more of its moving averages.

HIMS Yearly ROI

YearStart priceEnd priceROI
2020$9.89$15.0+51%
2021$15.0$6.65-56%
2022$6.65$6.43-3.3%
2023$6.43$8.90+38%
2024$8.90$26.6+198%
2025$26.6$34.3+29%
2026 YTD$34.3$19.7-42%

HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.

NOK Yearly ROI

YearStart priceEnd priceROI
2020$3.63$3.89+7.2%
2021$3.89$6.19+59%
2022$6.19$4.64-25%
2023$4.64$3.42-26%
2024$3.42$4.48+31%
2025$4.48$6.62+48%
2026 YTD$6.62$8.28+25%

NOK has the edge over HIMS on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key